Rocket Pharmaceuticals CFO Aaron Ondrey resigns to pursue other opportunities

In a regulatory filing, the company states: “On August 20, 2025, Aaron Ondrey resigned as Chief Financial Officer of Rocket Pharmaceuticals (RCKT), effective September 5, 2025, to pursue other opportunities. On August 25, 2025, Martin Wilson, the Company’s General Counsel and Chief Corporate Officer and the Company’s Corporate Secretary, was appointed as the Company’s interim Principal Financial Officer, effective September 8, 2025. Mr. Wilson joined the Company as General Counsel and Chief Compliance Officer in November 2021 and became Chief Corporate Officer in March 2024.”